*  Correlation of Factor VIIa Values With Factor VII Gene Polymorphism, Fasting and Postprandial Triglyceride Levels, and...
Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proc Natl ... Background-Factor VII plays a pivotal role in coagulation. Factor VIIc levels were reported to be a risk factor for fatal ... Factor VII plays a central role in initiation of coagulation reaction.1 The single-chain factor VII is inactive but becomes ... The factor VII AA genotype was associated with a higher factors VIIag and VIIc levels. It was associated with a higher factor ...
  http://circ.ahajournals.org/content/98/25/2815
*  GPM.3.3.2.0002.15 Human coagulation factor VII | Pharmacopoeia.ru
... factor VII Pharmacopoeia Monograph First Edition The present Pharmacopoeia Monograph applies to human coagulation factor VII ... "Determination of blood coagulation factor activity".. Human coagulation factor VII activity. Not less than 15 IU per millilitre ... coagulation factor VII activity / protein content. Coagulation factor IX activity. Coagulation factor IX activity, per vial or ... Human coagulation factor VII preparations may contain coagulation factors II, IX, and X, protein С and protein S, the content ...
  http://pharmacopoeia.ru/en/fs-3-3-2-0002-15-faktor-svertyvaniya-krovi-vii-cheloveka/
*  Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer. - Semantic...
Using Western blot, IHC, and immunofluorescent staining, we show persistent factor IX expression in injected muscle tissue. F. ... In previous work we transferred a human factor IX-encoding adeno-associated viral vector (AAV) into skeletal muscle of men with ... Blood}, year={2012}, volume={119 13}, pages={3038-41} }. ... Gene Therapy for Coagulation Disorders.. *Laura L Swystun. , ... AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.. *Catherine S Manno. , Amy J Chew ...
  https://www.semanticscholar.org/paper/Factor-IX-expression-in-skeletal-muscle-of-a-sever-Buchlis-Podsakoff/e3aa07b9e467618ed3042df27bf3b24075c60881
*  Factor VIII Market Share, Consumption and Revenue Forecast by Regions 2021
Hemophilia A, recessive Xlinked coagulation disorder orAntihemophilic factor also called factor VIII FVIII deficiency or ... a blood clotting protein. It affects about 1 in 5000 males. Factor VIII is a key factor of the intrinsic clotting cascade. ... Factor VIII Market is classified, by type into Recombinant Factor VIII, Plasmaderived Factor VIII. Factor VIII Market is ... Later on, recombinant factor VIII has been approved for therapeutic use, which lessens the risk of viral transmission. Factor ...
  http://b3.zcubes.com/v.aspx?mid=414850&
*  Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-FXa assays
analysis; anticogaulants; apixaban; blood coagulation tests; factorXa National Category Clinical Medicine Identifiers. URN: urn ... Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-FXa assays. Hillarp, A. ... To investigate the effects of apixaban on commonly used coagulation methods, and to evaluate anti-FXa assays for specific ... Apixaban is an oral direct factor Xa inhibitor developed for the prophylaxis and treatment of thromboembolic disorders. ...
  http://www.diva-portal.org/smash/record.jsf?pid=diva2:757216
*  Factor V Leiden Mutation and PT 20210 Mutation: The Test
... when Factor V Leiden mutation and PT 20210 mutation tests are ordered, and what the results of Factor V Leiden mutation and PT ... Describes how Factor V Leiden mutation and PT 20210 mutation tests are used, ... Factor V and prothrombin are two coagulation factors essential for proper blood clot formation. People who have a mutation in ... Also known as: Activated Protein C Resistance; APC Resistance; Factor V R506Q; PT G20210A; Factor II 20210; Factor II Mutation ...
  https://labtestsonline.org/understanding/analytes/factor-v-and-pt20210/tab/test
*  Coagulation factor XIa | Article about Coagulation factor XIa by The Free Dictionary
Find out information about Coagulation factor XIa. A procoagulant present in normal blood but deficient in hemophiliacs. Also ... known as plasma thromboplastin antecedent Explanation of Coagulation factor XIa ... Related to Coagulation factor XIa: Factor ixa factor XI. [′fak·tər ə′le·vən] (biochemistry) A procoagulant present in normal ... factor XI. (redirected from Coagulation factor XIa). Also found in: Dictionary, Thesaurus, Medical. ...
  https://encyclopedia2.thefreedictionary.com/Coagulation+factor+XIa
*  Design and synthesis of macrocyclic indoles targeting blood coagulation cascade Factor XIa
The synthesis of a series of novel macrocyclic compounds designed to target blood coagulation Factor XIa is described. The ... Design and synthesis of macrocyclic indoles targeting blood coagulation cascade Factor XIa. Hanessian, Stephen ... Several compounds displayed modest activity and good selectivity for Factor XIa. Within the series, a promising lead structure ...
  http://umu.diva-portal.org/smash/record.jsf?pid=diva2:372080
*  Coagulation Factor VII Antibodies: Novus Biologicals
Browse our Coagulation Factor VII Antibody catalog backed by our Guarantee+. ... Coagulation Factor VII Antibodies available through Novus Biologicals. ... Blood Coagulation Disorders (20). *. Carcinoma (20). *. Cardiovascular Diseases (20). *. Coronary Heart Disease (20) ...
  https://www.novusbio.com/gene-id/2155?related_pathways=Secretion
*  Clotting factors - Mnemonic - Ramneet Kaur - Medium
Christmas factor, Plasma thromboplastin component (PTC); intrinsic pathway; deficiency leads to hemophilia B. Factor XI - ... Clotting factors:. *The clotting factors are a group of chemicals in the blood which is responsible for the formation of blood ... Factor IV - Calcium ions (Ca2+); always present, needed for coagulation.. Factor V - Labile factor, Proaccelerin; common ... Factor VII - Stable factor, Proconvertin; both extrinsic & intrinsic pathway.. Factor VIII - Antihaemophilic factor (AHF); ...
  https://medium.com/@enulucky/clotting-factors-mnemonic-ef7e68b8c6ba
*  Factor XI - Wikipedia
"Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in ... "Coagulation factor XI: a database of mutations and polymorphisms associated with factor XI deficiency". Blood Coagulation & ... "Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency". Blood. 79 (6 ... factor XII, factor XI, and factor IX). Factor XIa activates factor IX by selectively cleaving arg-ala and arg-val peptide bonds ...
  https://en.wikipedia.org/wiki/Factor_XI
*  Fibrinopeptides, blood-coagulation factors or derivatives > Patents - Class: 514...
Factor VII glycoforms. Jun. 7, 2005. 6884616. DNA-construct for the tissue-specific expression of a blood coagulation factor. ... Process for the pasteurization of plasma or concentrates of blood coagulation factors II, VII, IX and X. Feb. 12, 2002. ... Name: Drug, bio-affecting and body treating compositions > Fibrinopeptides, blood-coagulation factors or derivatives. ... Description: Subject matter wherein the peptide composition is related to fibrinopeptides, blood-coagulation factors or ...
  http://www.patentgenius.com/class/514/802.html
*  IJMS | Free Full-Text | Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases
... with modulatory effects or modulated by the coagulation cascade have been reported to affect the pathophysiology of the central ... being able to interfere with synaptic homeostasis other than coagulation itself. These specific functions modulate neuronal ... Blood coagulation factors and other proteins, with modulatory effects or modulated by the coagulation cascade have been ... "Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases." Int. J. Mol. Sci. 18, no. 10: 2128. ...
  http://www.mdpi.com/1422-0067/18/10/2128
*  Cardiovascular & Blood : Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis
Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis. The "Coagulation Factors 2009: Target Pipeline and ... Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis. Publisher: La Merie Publishing ×. La Merie ... The market size of recombinant and plasma-derived coagulation factor products exceeded US$ 7.5 bln in 2008, the majority (US$ ... The authors analyze and assess the target pipeline for each of the coagulation factors used for systemic and topical ...
  http://pipelinereview.com/index.php/therapeuticarea/cardiovascular/coagulation-factors-2009-target-pipeline-and-corporate-benchmar-detail
*  Collaborative study on the 2nd International Standard for Blood Coagulation Factor XI, Plasma (‎15/180)‎: assignment of...
2016)‎. Collaborative study on the 2nd International Standard for Blood Coagulation Factor XI, Plasma (‎15/180)‎: assignment of ... Collaborative study on the 1st international standard for blood coagulation factor XII, plasma: assignment of functional (‎FXII ... Collaborative study on the 2nd International Standard for Blood Coagulation Factor XI, Plasma (‎15/180)‎: assignment of ... Collaborative study for value assignment of the 4th [‎fourth]‎ international standard for factors II, VII, IX, X, plasma / by ...
  http://apps.who.int/iris/handle/10665/253047
*  Controlled assembly of peptide-functionalized gold nanoparticles for label-free detection of blood coagulation Factor XIII...
Activated Factor XIII catalyzes the formation of covalent crosslinking between peptide chains through ε-(γ- ... A highly sensitive label-free assay for the determination of blood coagulation Factor XIII activity is demonstrated through the ... A highly sensitive label-free assay for the determination of blood coagulation Factor XIII activity is demonstrated through the ... Controlled assembly of peptide-functionalized gold nanoparticles for label-free detection of blood coagulation Factor XIII ...
  http://pubs.rsc.org/en/Content/ArticleLanding/2014/CC/C4CC00572D?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+rss%2FCC+%28RSC+-+Chem.+Commun.+latest+articles%29
*  Expression and characterization of a codonoptimized blood coagulation factor VIII - Surrey Research Insight Open Access
Expression and characterization of a codon-optimized blood coagulation factor VIII. J Thromb Haemost 2017; 15: 709-20, which ... Coagulation Factor VIII; LRP1 protein, human; von Willebrand Factor, Lentivirus; Hemophilia A ... Expression and characterization of a codonoptimized blood coagulation factor VIII Journal of Thrombosis and Haemostasis, 15 (4 ... Background: Production of recombinant factor VIII (FVIII) is challenging due to its low expression. It was previously shown ...
  http://epubs.surrey.ac.uk/813284/
*  Global Blood Coagulation Testing Market Growth Opportunities, Key Driven Factors, Market Scenario Fo
Global Blood Coagulation Testing Market Information by instruments (prothrombin time, APTT, thrombo test) by methods (Global ... Pune, Maharashtra -- (SBWIRE) -- 01/25/2017 -- Market Synopsis of Blood Coagulation Testing Market:. Blood Coagulation Testing ... Global Blood Coagulation Testing Market Growth Opportunities, Key Driven Factors, Market Scenario Forecast to 2027. Global ... To provide insights about factors affecting the market growth. - To Analyze the Global Blood Coagulation Testing Market based ...
  http://www.sbwire.com/press-releases/global-blood-coagulation-testing-market-growth-opportunities-key-driven-factors-market-scenario-forecast-to-2027-764331.htm
*  Cardiovascular & Blood : Coagulation Factors 2011 - who does meet the market needs? A Pipeline Assessment, Market Survey and...
3 Coagulation Factor Markets. 3.1 Recombinant Factor VIIIa Market 3.2 Recombinant Factor IXa Market 3.3 Recombinant Factor VIIa ... 5.1 Factor VIII 5.2 Factor IX 5.3 Factor VII 5.4 Alternative Procoagulants & Adjuncts 5.5 Factor XIII 5.6 von Willebrand Factor ... Coagulation Factors 3.7 Plasma-Derived Coagulation Factors. 4 Pipeline Changes since September 2010 4.1 Alnylam Pharmaceuticals ... Table 47 Pharmstandard's Coagulation Factor Pipeline Table 48 Pfizer's Coagulation Factor Pipeline Table 49 Pfizer's Strategic ...
  http://pipelinereview.com/index.php/therapeuticarea/cardiovascular/coagulation-factors-2011-who-does-meet-the-market-needs-a-pi-detail
*  Whole blood platelet aggregation and coagulation factors in pa...
Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis.: It is unclear whether the ... Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis.. Authors * Goodfield, M J ... Plasma levels of fibrinogen, von Willebrand factor antigen and factor VIII:C were also measured. Systemic sclerosis was ... Whole blood platelet aggregation was studied in 26 patients with systemic sclerosis, normal subjects matched for age, sex and ...
  https://www.mysciencework.com/publication/show/whole-blood-platelet-aggregation-coagulation-factors-patients-systemic-sclerosis-07739a37
*  GPM.1.8.2.0003.15 Determination of blood coagulation factors activity | Pharmacopoeia.ru
GPM.1.8.2.0003.15 Determination of blood coagulation factors activity Ministry of Health of the Russian Federation General ... Coagulation factor activity testing is based on two approaches:. *One-step method. Blood coagulation recovered in factor ... Factor X * Clot-based method.. Factor X is determined using human factor X-deficient plasma as the substrate. The coagulation ... Factor VIII is assayed using a set of reagents in which factor VIII serves as a co-factor for factor IХа during activation of ...
  http://pharmacopoeia.ru/en/ofs-1-8-2-0003-15-opredelenie-aktivnosti-faktorov-svertyvaniya-krovi/
*  DMOZ - Health: Conditions and Diseases: Blood Disorders: Coagulation Disorders: Factor V Leiden
... is a hereditary blood disorder that causes hypercoagulability and an increased risk of thrombosis. ... Factor V Leiden, also known as Activated Protein C Resistance, ... Support for sufferers of the Factor Five Leiden blood clotting ... Health Conditions and Diseases Blood Disorders Coagulation Disorders Factor V Leiden 2 ... Factor V Leiden, also known as Activated Protein C Resistance, is a hereditary blood disorder that causes hypercoagulability ...
  http://dmoztools.net/Health/Conditions_and_Diseases/Blood_Disorders/Coagulation_Disorders/Factor_V_Leiden/
*  US5437864A - Method of inhibiting blood coagulation in extracorporeal circulation by inhibiting human tissue factor -...
The method prevents complex formation between tissue factor and factor VII/VIIa and thus inhibits coagulation of blood in ... Anti-tissue factor monoclonal antibodies produced by hybridoma cell lines TFS-5G9 or TF9-6B4 may be used in the claimed methods ... of a therapeutically effective amount of a monoclonal antibody which inhibits the ability of tissue factor to bind to factor ... This invention provides a method of inhibiting coagulation in extracorporeal circulation in a subject, comprising ...
  https://patents.google.com/patent/US5437864?oq=flatulence